European Companies Search Engine
EU funding (€6,000,000): Patient Preferences in benefit risk assessments during the drug life cycle - Sofia ref.: 115966 Hor 1 Oct 2016 EU Research and Innovation programme "Horizon"
Overview
Text
This publication is not available.
The filing refers to a past date, and does not necessarily reflect the current state.